Web Stats Provided By Google Analytics

The Raw Stem Cell News Feed

The Stem Cell Research Newswire: Comprehensive Real-Time News Feed for Stem Cell Research

Friday, August 22, 2014

Sunesis Pharmaceuticals, Inc. Offers A Moderate Risk 80% Return On The Short Side

Sunesis Pharmaceuticals is nearing a binary event with the top-line data readout of its Phase 3 Valor trial that is expected any day now.

http://ift.tt/1qwMX35

No comments:

Post a Comment

Popular Stem Cell Roundup Posts